Telomeregenic
Telogenix™
Pineal · Longevity · Telomerase
The longevity axis. Telomere-supportive bioregulator at the cellular-aging interface.
Applications
Longevity · Aging · Biological-Age Endpoints
The Opticeutical Category
Optimized nutraceuticals, grounded in science.
Bioregulator-grounded formulations for daily wellness, longevity support, and tissue-specific care. Designed under cGMP discipline. Verified per batch. Anchored in four decades of peer-reviewed endogenous research.
As Featured On
Founding-team work on the public record.
Ian Clark, Founding Curator at Atumnus Life Sciences, has appeared in long-form on the shows below and 17+ others. The full archive is published with editorial commentary on this site.
Biohack Yourself Documentary
Kwik Brain with Jim Kwik
SuperLife with Darin Olien
Ben Greenfield Life
Wellness Force / Josh Trent
The Melanie Avalon Biohacking Podcast
The Chris Voss Show
What Happens in Vagus
Get Lean Eat Clean
Wellness + Wisdom
Mindfulness Mode
Wellness is Life
Living Holistically
Far Out With Faust
Michael Stein Media
FemiNinja Project
Biohack Yourself Documentary
Kwik Brain with Jim Kwik
SuperLife with Darin Olien
Ben Greenfield Life
Wellness Force / Josh Trent
The Melanie Avalon Biohacking Podcast
The Chris Voss Show
What Happens in Vagus
Get Lean Eat Clean
Wellness + Wisdom
Mindfulness Mode
Wellness is Life
Living Holistically
Far Out With Faust
Michael Stein Media
FemiNinja Project
Portfolio Coverage
Seven trade-named compounds. Seven coverage areas. One category.
Atumnus Life Sciences holds a portfolio of trade-named, patent-pending peptide-class bioregulator compounds covering the principal regulatory axes of human physiology — from cellular longevity and immune resilience to vascular, neural, dermal, and reproductive regeneration. Every compound is independently formulated under the Opticeutical Standard.
Immunoregenic
Thymogenix™
Thymic restoration · T-cell competence
The thymic axis. Immune-restoration bioregulator at the thymic-output interface.
Applications
Immune Resilience · Recovery · Senescence
Immunoregenic
Lymphogenix™
Lymphoid · Mucosal immunity
The mucosal axis. Lymphoid-supportive bioregulator at the mucosal-immunity interface.
Applications
Mucosal · GI · Respiratory
Neuroregenic
Cortigenix™
Cognition · Neuroprotection
The cognitive axis. Neuro-supportive bioregulator at the cortical and hippocampal interface.
Applications
Cognitive · Neuroprotective · Performance
Vasoregenic
Vasogenix™
Endothelial · Anti-atherogenic
The vascular axis. Endothelial-supportive bioregulator at the vascular-integrity interface.
Applications
Cardiovascular · Recovery · Longevity
Dermoregenic
Dermogenix™
Skin · Wound · ECM remodeling
The dermal axis. Connective-tissue-supportive bioregulator at the collagen and ECM-remodeling interface.
Applications
Skin · Wound Healing · Connective Tissue · Oral / Dental
Genoregenic
Gonadogenix™
Reproductive · Endocrine · Longevity
The reproductive axis. Gonadal-supportive bioregulator at the endocrine-longevity interface.
Applications
Reproductive · Endocrine · Longevity
Stack class
Multiregenic™
Multi-organ-axis combinations
Combinations of two or more bioregulators in a single formulation, addressing multi-axis interventions where individual compounds alone would underdeliver against the application requirement.
Multi-axis stack formulations are the architectural advantage the bioregulator class provides: an intervention that operates across multiple regulatory systems simultaneously, rather than a single-target compound asking one system to compensate for deficits across all the others.
Coverage at a Glance
Seven coverage areas. Mapped to the portfolio.
| Coverage area | Anchored by |
|---|---|
| Longevity & Cellular Aging | Telogenix™ |
| Immune Resilience | Thymogenix · Lymphogenix™ |
| Cognitive & Neuroprotective | Cortigenix™ |
| Cardiovascular & Vascular | Vasogenix™ |
| Skin, Dermal & Connective Tissue | Dermogenix™ |
| Reproductive & Endocrine | Gonadogenix™ |
| Oral, Dental & Mucosal | Dermogenix · Lymphogenix™ |
All compound trade names referenced are trademarks of Atumnus Life Sciences. The portfolio is protected by issued patents and pending applications across composition, formulation, manufacturing, delivery, administration, and combination architecture.
Product Lines
The first product lines under the Opticeutical Standard.
The category exists, the standard is published, the IP is in place, and the first product lines are in production — spanning oral care, systemic performance, and skincare. Each pairs trade-named peptide-class bioregulators with the manufacturing and verification discipline the standard requires.
First commercial product line
OptiOral™ Care
The first line formulated under the full six-pillar Opticeutical Standard. Targeted oral, dental, and gingival regenerative support, from chairside to daily home use.
Performance · Clinical · Veterinary
HelioMend™
A multi-axis systemic line combining trade-named peptide-class bioregulators across complementary regenerative axes, formulated under the Opticeutical Standard.
Skincare & longevity
HelioMystic™
A skincare and longevity line built on Dermogenix™ and Telogenix™ bioregulators, formulated to support the look and feel of healthy, resilient skin.
The Arc
Five decades of research. Two decades of curation. One category.
The Opticeutical category is not a product launch. It is the institutional naming of a discipline that has been operating, in parts, for over fifty years. The arc from foundational research through founder curation through public category authority.
- 1971Founding research
The bioregulator research lineage begins.
The St. Petersburg Institute of Bioregulation and Gerontology and collaborating Eastern European institutions begin the multi-decade investigation of short-chain regulatory peptides that becomes the foundational science of the category.
1971Founding researchThe bioregulator research lineage begins.
The St. Petersburg Institute of Bioregulation and Gerontology and collaborating Eastern European institutions begin the multi-decade investigation of short-chain regulatory peptides that becomes the foundational science of the category.
- 2004Founder origin
Ian Clark's natural-protocol recovery.
Following a tumor diagnosis and dire prognosis at 46, Ian Clark addresses his health crisis through natural means rather than conventional intervention — the inflection that becomes Activation Products and two decades of natural-formulation curation.
2004Founder originIan Clark's natural-protocol recovery.
Following a tumor diagnosis and dire prognosis at 46, Ian Clark addresses his health crisis through natural means rather than conventional intervention — the inflection that becomes Activation Products and two decades of natural-formulation curation.
- 2014Activation Products
Activation Products founded.
Ian Clark and son Anthony co-found Activation Products, the direct-to-consumer natural formulation company that builds the sourcing relationships and personal-validation discipline that the Opticeutical Standard now formalizes.
2014Activation ProductsActivation Products founded.
Ian Clark and son Anthony co-found Activation Products, the direct-to-consumer natural formulation company that builds the sourcing relationships and personal-validation discipline that the Opticeutical Standard now formalizes.
- 2021Mainstream recognition
Kwik Brain Podcast #242.
Jim Kwik introduces Ian to the Mindvalley-adjacent mainstream brain optimization audience as a long-time friend and wellness sage. The first tier-one mainstream platform appearance.
2021Mainstream recognitionKwik Brain Podcast #242.
Jim Kwik introduces Ian to the Mindvalley-adjacent mainstream brain optimization audience as a long-time friend and wellness sage. The first tier-one mainstream platform appearance.
- 2024Documentary feature
Biohack Yourself Documentary Series.
Ian appears in the feature-length Biohack Yourself documentary series alongside Robert F. Kennedy Jr., Dave Asprey, Daniel Amen, Mindy Pelz, Ben Greenfield, Luke Storey, Nathan Bryan, and Christina Rahm. The strongest co-billing credibility asset in the catalog.
2024Documentary featureBiohack Yourself Documentary Series.
Ian appears in the feature-length Biohack Yourself documentary series alongside Robert F. Kennedy Jr., Dave Asprey, Daniel Amen, Mindy Pelz, Ben Greenfield, Luke Storey, Nathan Bryan, and Christina Rahm. The strongest co-billing credibility asset in the catalog.
- 2026Category published
Opticeuticals defined as a category.
Atumnus Life Sciences publishes the Opticeutical category and the six-pillar Opticeutical Standard. A new category designation for optimized nutraceuticals built on bioregulator-grounded science, formulation discipline, and verifiable mechanism rationale.
2026Category publishedOpticeuticals defined as a category.
Atumnus Life Sciences publishes the Opticeutical category and the six-pillar Opticeutical Standard. A new category designation for optimized nutraceuticals built on bioregulator-grounded science, formulation discipline, and verifiable mechanism rationale.
- 2026Founding Curator
Activation Products and Atumnus collaboration.
Activation Products and Atumnus Life Sciences announce a strategic collaboration under which Ian Clark joins the Atumnus founding team as Founding Curator. The bioregulator IP portfolio meets two decades of natural-formulation expertise.
2026Founding CuratorActivation Products and Atumnus collaboration.
Activation Products and Atumnus Life Sciences announce a strategic collaboration under which Ian Clark joins the Atumnus founding team as Founding Curator. The bioregulator IP portfolio meets two decades of natural-formulation expertise.
- 2026First products
OptiOral Care and HelioMend in production.
The first product lines formulated under the full six-pillar Opticeutical Standard enter production. Trade-named, patent-pending peptide-class bioregulators delivered through the trade-named platform portfolio with Opti-Salt™ carrier chemistry.
2026First productsOptiOral Care and HelioMend in production.
The first product lines formulated under the full six-pillar Opticeutical Standard enter production. Trade-named, patent-pending peptide-class bioregulators delivered through the trade-named platform portfolio with Opti-Salt™ carrier chemistry.
Working Definition
An Opticeutical is a bioregulator-grounded nutraceutical formulated for over-the-counter consumer access. Designed under cGMP discipline. Verified per batch. Built on the published bioregulator research lineage.
Opticeuticals is the consumer tier of bioregulatory medicine. The prescription tier is Endoceuticals. Both are expressions of the same scientific discipline, served through different distribution channels.
Reference Anchors
Anchored in published science and established standards.
800+
Peer-reviewed publications.
The Eastern European bioregulator research lineage, across four decades and multiple institutional laboratories.
1994
DSHEA framework.
The Opticeutical category sits within the established food and supplement regulatory framework. No new regulatory class.
2023
Hallmarks of Aging.
The Cell 2023 update places bioregulator mechanisms at the intersection of epigenetic alteration, intercellular communication, and the glycation-driven protein damage axis.
ISO 17025
Per-batch verification.
Every batch verified by accredited third-party laboratories. Identity, potency, and contaminant load on every production run.
Explore
The science, the standard, the method, the platforms.
The Science
Bioregulators
The therapeutic class behind every Opticeutical. How short peptide bioregulators interact with the body's own regulatory architecture — anchored in four decades of peer-reviewed research.
Read →The Standard
What Qualifies
The qualification criteria a product must meet to be designated an Opticeutical. Formulation, sourcing, verification, and manufacturing discipline — the same logic across every product in the category.
Read →The Method
How It's Made
From compound to consumer-ready format. Topical, transdermal, intranasal, sublingual, and oral delivery. cGMP discipline. ISO 17025 per-batch verification.
Read →The Platforms
Delivery
The branded delivery technologies that carry Opticeuticals into the body — designed for the route, dosage, and use case each formulation requires.
Read →On the Founding Team
Voices on the record.
“A long-time friend and a wellness sage.”
Jim Kwik
Introducing Ian Clark on Kwik Brain Podcast #242
“I am now healthier than I ever dreamed I could be, far healthier than I ever would have been in my life.”
Ian Clark
Biohack Yourself Documentary Series, 2024
“Your most important asset is your body. If you lose your body, you get cut off from every single thing you have.”
Ian Clark
Biohack Yourself Documentary Series, 2024
“Once you find the essential nutrients in the purest form, you can double, triple, and quadruple your performance.”
Ian Clark
Kwik Brain Podcast #242, August 2021
Latest
What's been published.
·Partnership
Activation Products and Atumnus Life Sciences Announce Formulation Collaboration for the Opticeutical Category
Activation Products founder Ian Clark joins Atumnus Life Sciences as Founding Curator. The two organizations begin formal collaboration on peptide-class bioregulator formulations developed under the Opticeutical Standard.
Read article →
·Intellectual Property
The Delivery Platform Portfolio: Trade-Named, Patent-Pending Across the Full Stack
An overview, at the level publicly statable during ongoing prosecution, of the trade-named delivery platform portfolio and the IP architecture beneath the Opticeutical category.
Read article →
·Standard
The Opticeutical Standard: Six Pillars, Published in Full
The published six-pillar standard governing what may bear the Opticeutical designation — composition rigor, bioavailability, mechanism rationale, third-party verification, manufacturing discipline, sourcing integrity. No partial qualification.
Read article →
Stay Close to the Category
Products are coming. Be among the first to know.
Opticeuticals is in late-stage development. Practitioners, distributors, and media inquiries welcome. Consumer launch notifications available by request.